Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

118.76
-1.8050-1.50%
Volume:188.73K
Turnover:22.50M
Market Cap:11.75B
PE:40.16
High:120.10
Open:119.67
Low:118.39
Close:120.56
Loading ...
Aug 03, 2020

Major Issues Report

8-K - Current report
Jul 28, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 09, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 04, 2020

Major Issues Report

Current report, items 2.02, 5.02, 5.03, and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Dec 11, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership